[Information provided by:
ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]
|NCT02052024 : Myobloc Atrophy Study|
|Ages||Min: 18 Years Max: N/A|
- Men and women aged 18 or older with spasticity secondary to either a disorder or
trauma, such as a spinal cord injury (SCI), a brain injury, a tumor, a stroke,
multiple sclerosis (MS), or a peripheral nerve injury.
- Participants must have the ability to provide written consent to participate in the
- Patients who have received BTX-A or BTX-B in the past in the skeletal muscle group
under investigation or patients who have had an allergic response to BTX-A or BTX-B
in the past.
- Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, or Amyotrophic Lateral
Sclerosis. Females who are pregnant or breastfeeding. Subjects taking Aminoglycosides
or other agents interfering with neuromuscular function.
|Links||Permanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02052024
| Link to official Clinicaltrials.gov listing